Skip to main content
. Author manuscript; available in PMC: 2026 Oct 18.
Published in final edited form as: J Am Coll Cardiol. 2026 Apr 14;87(14):1798–1813. doi: 10.1016/j.jacc.2026.01.087

TABLE 2.

Screening Effect Across Quartiles of AF Risk

Score Quartile AF Incidence in Screened Group (95% CI) (per 100 person-y) AF Incidence in Control Group (95% CI) (per 100 person-y) Difference in AF Incidence (95% CI) (per 100 person-y)
CHARGE-AF 1 1.02 (0.69-1.35) 0.62 (0.36-0.88) 0.40 (−0.03 to 0.82)
2 1.10 (0.75-1.46) 1.11 (0.78-1.45) −0.01 (−0.50 to 0.48)
3 2.22 (1.71-2.73) 2.44 (1.94-2.94) −0.22 (−0.94 to 0.49)
4 5.62 (4.79-6.46) 5.13 (4.40-5.86) 0.49 (−0.62 to 1.60)

ECG-AI 1 1.08 (0.73-1.44) 0.79 (0.50-1.08) 0.29 (−0.16 to 0.75)
2 1.00 (0.66-1.34) 1.24 (0.88-1.60) −0.24 (−0.74 to 0.25)
3 2.37 (1.84-2.89) 2.86 (2.32-3.41) −0.50 (−1.25 to 0.26)
4 5.33 (4.53-6.13) 4.49 (3.80-5.17) 0.84 (−0.21 to 1.90)

CH-AI 1 0.76 (0.48-1.05) 0.51 (0.28-0.75) 0.25 (−0.12 to 0.62)
2 1.33 (0.94-1.73) 0.90 (0.59-1.20) 0.44 (−0.06 to 0.93)
3 1.97 (1.49-2.44) 2.58 (2.07-3.10) −0.62 (−1.32 to 0.09)
4 5.93 (5.07-6.79) 5.32 (4.57-6.06) 0.61 (−0.53 to 1.75)

Abbreviations as in Table 1.